Clinical trial
Reflectance Confocal Microscopy Evaluation of Skin Structure of Patients With Atopic Dermatitis Under Nemolizumab
NCT07730788 is registered in ClinicalTrials.gov with Hôpitaux Drôme Nord as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Reflectance Confocal Microscopy Evaluation of Skin Structure of Patients With Atopic Dermatitis Under Nemolizumab
- Lead sponsor
- Hôpitaux Drôme Nord
- Phase
- Observational
- Overall status
- Recruiting
- Start date
- June 11, 2026
- Completion date
- June 11, 2028
- Enrollment
- 15 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
atopic dermatitis (ad), atopic dermatitis (eczema)